Fibrinogen and Fibrin in Hemostasis and Thrombosis.
暂无分享,去创建一个
[1] H. Gaylis. Venous thrombosis. , 2020, South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie.
[2] P. Boor,et al. Clot Structure: A Potent Mortality Risk Factor in Patients on Hemodialysis. , 2017, Journal of the American Society of Nephrology : JASN.
[3] C. Haynes,et al. Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA. , 2017, Blood.
[4] R. Pawlinski,et al. In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps. , 2017, Blood.
[5] J. Weisel,et al. Contraction of Blood Clots Is Impaired in Acute Ischemic Stroke , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[6] A. Undas,et al. Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[7] A. Fogelson,et al. Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating Coagulation , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[8] A. Wolberg,et al. The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits. , 2016, Blood.
[9] Marco M. Domingues,et al. Polyphosphate Delays Fibrin Polymerisation and Alters the Mechanical Properties of the Fibrin Network , 2016, Thrombosis and Haemostasis.
[10] A. Gruber,et al. Factor XI as a Therapeutic Target , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[11] F. Leebeek,et al. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII , 2016, Journal of thrombosis and haemostasis : JTH.
[12] P. de Moerloose,et al. The Role of Fibrinogen and Factor XIII in Hemostasis, and the Identification and Treatment of Associated Disorders , 2016, Seminars in Thrombosis & Hemostasis.
[13] S. Diamond,et al. Transport physics and biorheology in the setting of hemostasis and thrombosis , 2016, Journal of thrombosis and haemostasis : JTH.
[14] R. Porte,et al. Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen , 2016, Journal of thrombosis and haemostasis : JTH.
[15] J. Heemskerk,et al. Platelet Control of Fibrin Distribution and Microelasticity in Thrombus Formation Under Flow , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[16] V. Schroeder,et al. Factor XIII: Structure and Function , 2016, Seminars in Thrombosis & Hemostasis.
[17] D. Harats,et al. Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[18] C. Maas,et al. Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[19] H. Philippou,et al. Factor XIII A-Subunit V34L Variant Affects Thrombus Cross-Linking in a Murine Model of Thrombosis , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[20] Marco M. Domingues,et al. Thrombin and fibrinogen γ' impact clot structure by marked effects on intrafibrillar structure and protofibril packing. , 2016, Blood.
[21] Lorna M. Lopez,et al. A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration. , 2016, Human molecular genetics.
[22] J. Weisel,et al. Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood. , 2016, Blood.
[23] J. Weisel,et al. Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots , 2015, Scientific Reports.
[24] D. Dwivedi,et al. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[25] A. Folsom,et al. Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study. , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[26] D. Weitz,et al. Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure , 2015, Thrombosis and Haemostasis.
[27] W. Lam,et al. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking. , 2015, Blood.
[28] D. Izquierdo-Garcia,et al. Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in Rats , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[29] Uwe Völker,et al. Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF. , 2015, Blood.
[30] A. Casini,et al. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management , 2015, Journal of thrombosis and haemostasis : JTH.
[31] Stephanie A. Smith,et al. 2013 scientific sessions Sol Sherry distinguished lecture in thrombosis: polyphosphate: a novel modulator of hemostasis and thrombosis. , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[32] M. Budoff,et al. Relationship of Cigarette Smoking With Inflammation and Subclinical Vascular Disease: The Multi-Ethnic Study of Atherosclerosis , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[33] D. Klinov,et al. Visualization of fibrinogen αC regions and their arrangement during fibrin network formation by high‐resolution AFM , 2015, Journal of thrombosis and haemostasis : JTH.
[34] S. Diamond,et al. Fibrin, &ggr;′-Fibrinogen, and Transclot Pressure Gradient Control Hemostatic Clot Growth During Human Blood Flow Over a Collagen/Tissue Factor Wound , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[35] G. Raskob,et al. Factor XI antisense oligonucleotide for prevention of venous thrombosis. , 2014, The New England journal of medicine.
[36] A. Houng,et al. Microvascular Thrombosis, Fibrinolysis, Ischemic Injury, and Death After Cerebral Thromboembolism Are Affected by Levels of Circulating &agr;2-Antiplasmin , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[37] S. Diamond,et al. A systems approach to hemostasis: 3. Thrombus consolidation regulates intrathrombus solute transport and local thrombin activity. , 2014, Blood.
[38] D. Dwivedi,et al. Neutrophil Extracellular Traps Promote Thrombin Generation Through Platelet-Dependent and Platelet-Independent Mechanisms , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[39] K. Brummel-Ziedins,et al. Global assays of hemostasis , 2014, Current opinion in hematology.
[40] W. Lam,et al. Factor XIII activity mediates red blood cell retention in venous thrombi. , 2014, Journal of Clinical Investigation.
[41] B. Monia,et al. Factor XI Regulates Pathological Thrombus Formation on Acutely Ruptured Atherosclerotic Plaques , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[42] Betti Giusti,et al. Oxidative Modification of Fibrinogen Is Associated With Altered Function and Structure in the Subacute Phase of Myocardial Infarction , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[43] A. Wolberg,et al. Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency , 2014, Journal of thrombosis and haemostasis : JTH.
[44] René M. Botnar,et al. Fibrin-Targeted Magnetic Resonance Imaging Allows In Vivo Quantification of Thrombus Fibrin Content and Identifies Thrombi Amenable for Thrombolysis , 2014, Arteriosclerosis, Thrombosis and Vascular Biology.
[45] W. Bergmeier,et al. The fibrinogen γA/γ′ isoform does not promote acute arterial thrombosis in mice , 2014, Journal of thrombosis and haemostasis : JTH.
[46] É. Katona,et al. Interaction of factor XIII subunits. , 2014, Blood.
[47] L. Rauova,et al. Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. , 2014, Blood.
[48] M. Poncz,et al. Modulation of Protein C Activation by Histones, Platelet Factor 4, and Heparinoids: New Insights Into Activated Protein C Formation , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[49] B. Lämmle,et al. Plasma DNA is Elevated in Patients with Deep Vein Thrombosis. , 2013, Journal of vascular surgery. Venous and lymphatic disorders.
[50] A. Wolberg,et al. Elevated Prothrombin Promotes Venous, but Not Arterial, Thrombosis in Mice , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[51] A. Gruber,et al. Antithrombotic Effect of Antisense Factor XI Oligonucleotide Treatment in Primates , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[52] T. Orfeo,et al. Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation. , 2012, Blood.
[53] D. Cook,et al. Prognostic utility and characterization of cell-free DNA in patients with severe sepsis , 2012, Critical Care.
[54] S. Connell,et al. Evidence that fibrinogen γ′ directly interferes with protofibril growth: implications for fibrin structure and clot stiffness , 2012, Journal of thrombosis and haemostasis : JTH.
[55] B. Polack,et al. Antithrombin-Independent Effects of Heparins on Fibrin Clot Nanostructure , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[56] Elie A Akl,et al. Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2013 .
[57] R. Ajjan,et al. Clot Architecture Is Altered in Abdominal Aortic Aneurysms and Correlates With Aneurysm Size , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[58] Paul J. Harrison,et al. Differential contributions of monocyte‐ and platelet‐derived microparticles towards thrombin generation and fibrin formation and stability , 2011, Journal of thrombosis and haemostasis : JTH.
[59] Kiril Tenekedjiev,et al. Lytic Resistance of Fibrin Containing Red Blood Cells , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[60] A. Wolberg,et al. Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. , 2011, Blood.
[61] K. Tenekedjiev,et al. Hindered dissolution of fibrin formed under mechanical stress , 2011, Journal of thrombosis and haemostasis : JTH.
[62] A. Balmforth,et al. Interactions between factor XIII and the alphaC region of fibrinogen. , 2011, Blood.
[63] S. Lord,et al. Molecular Mechanisms Affecting Fibrin Structure and Stability , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[64] I. Komáromi,et al. Factor XIII: novel structural and functional aspects , 2011, Journal of thrombosis and haemostasis : JTH.
[65] J. Weisel,et al. Flow rate and fibrin fiber alignment , 2010, Journal of thrombosis and haemostasis : JTH.
[66] S. Antonarakis,et al. Regulation of fibrinogen production by microRNAs. , 2010, Blood.
[67] Robert A. Campbell,et al. Flow profoundly influences fibrin network structure: Implications for fibrin formation and clot stability in haemostasis , 2010, Thrombosis and Haemostasis.
[68] J. Hartwig,et al. Extracellular DNA traps promote thrombosis , 2010, Proceedings of the National Academy of Sciences.
[69] N. Santos,et al. Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes. , 2010, ACS nano.
[70] P. Holt,et al. Indications for Catheter-Directed Thrombolysis in the Management of Acute Proximal Deep Venous Thrombosis , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[71] Z. Siudak,et al. Altered Plasma Fibrin Clot Properties Are Associated With In-Stent Thrombosis , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[72] D. Margosan,et al. Effects of Cigarette Smoke Exposure on Clot Dynamics and Fibrin Structure: An Ex Vivo Investigation , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[73] J. Weisel,et al. Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes , 2009, Thrombosis and Haemostasis.
[74] Alisa S Wolberg,et al. Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. , 2009, Blood.
[75] W. Tracz,et al. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives. , 2009, Blood.
[76] U. Seligsohn. Factor XI deficiency in humans , 2009, Journal of thrombosis and haemostasis : JTH.
[77] O. McCarty,et al. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. , 2009, Blood.
[78] H. Weiler,et al. Thrombosis risk modification in transgenic mice containing the human fibrinogen thrombin‐binding γ′ chain sequence , 2009, Journal of thrombosis and haemostasis : JTH.
[79] Alisa S Wolberg,et al. Cellular Procoagulant Activity Dictates Clot Structure and Stability as a Function of Distance From the Cell Surface , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[80] O. McCarty,et al. γA/γ’ fibrinogen inhibits thrombin-induced platelet aggregation , 2008, Thrombosis and Haemostasis.
[81] M. Hoffman. Alterations of fibrinogen structure in human disease. , 2008, Cardiovascular & hematological agents in medicinal chemistry.
[82] T. Wakefield,et al. Mechanisms of venous thrombosis and resolution. , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[83] J. Weitz,et al. Bivalent Binding to γA/γ′-Fibrin Engages Both Exosites of Thrombin and Protects It from Inhibition by the Antithrombin-Heparin Complex* , 2008, Journal of Biological Chemistry.
[84] S. Lord,et al. B:b interactions are essential for polymerization of variant fibrinogens with impaired holes ‘a’ 1 , 2007, Journal of thrombosis and haemostasis : JTH.
[85] James H Morrissey,et al. Polyphosphate enhances fibrin clot structure. , 2007, Blood.
[86] S. Hanson,et al. Fibrinogen γ′ chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway , 2007, British journal of haematology.
[87] J. Weisel. Structure of fibrin: impact on clot stability , 2007, Journal of thrombosis and haemostasis : JTH.
[88] Alisa S Wolberg,et al. Thrombin generation and fibrin clot structure. , 2007, Blood reviews.
[89] A. Hamsten,et al. Elevated plasma fibrinogen γ′ concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors , 2007, Journal of thrombosis and haemostasis : JTH.
[90] P. Simpson‐Haidaris,et al. Plasma fibrinogen γ′ chain content in the thrombotic microangiopathy syndrome , 2007 .
[91] M. Horne,et al. The effect of red blood cells on thrombin generation , 2006, British journal of haematology.
[92] J. Houwing-Duistermaat,et al. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. , 2005, Blood.
[93] Alisa S Wolberg,et al. High dose factor VIIa improves clot structure and stability in a model of haemophilia B , 2005, British journal of haematology.
[94] L. Almasy,et al. A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[95] R. Hantgan,et al. Endothelial Cells Organize Fibrin Clots into Structures That Are More Resistant to Lysis , 2004, Microscopy and Microanalysis.
[96] M. Burns,et al. Case-Control Study , 2020, Definitions.
[97] J. Oliver,et al. Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system , 2004, Journal of thrombosis and haemostasis : JTH.
[98] J. Weisel,et al. Influence of &ggr;′ Fibrinogen Splice Variant on Fibrin Physical Properties and Fibrinolysis Rate , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[99] R. Ariëns,et al. Fibrinogen gamma-chain splice variant γ′ alters fibrin formation and structure , 2003 .
[100] Sergiy Yakovlev,et al. Interaction of fibrin(ogen) with heparin: further characterization and localization of the heparin-binding site. , 2003, Biochemistry.
[101] M. Blombäck,et al. The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX , 2003, Journal of thrombosis and haemostasis : JTH.
[102] J. Weisel,et al. Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk , 2003, The Lancet.
[103] A. Wolberg,et al. Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. , 2003, Blood.
[104] P. Grant,et al. Altered Fibrin Clot Structure in the Healthy Relatives of Patients With Premature Coronary Artery Disease , 2002, Circulation.
[105] A. Wolberg,et al. Analyzing fibrin clot structure using a microplate reader , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[106] H. Ni,et al. Association of (cid:2) A/ (cid:2) ’ Fibrinogen Levels and Coronary Artery Disease , 2022 .
[107] S. Brennan,et al. The Amino Acid Sequence in Fibrin Responsible for High Affinity Thrombin Binding , 2001, Thrombosis and Haemostasis.
[108] J. Soria,et al. Disaggregation of In Vitro Preformed Platelet-Rich Clots by Abciximab Increases Fibrin Exposure and Promotes Fibrinolysis , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[109] I. Mochalkin,et al. A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[110] L. Lorand,et al. Structural origins of fibrin clot rheology. , 1999, Biophysical journal.
[111] J. Herbert,et al. Contribution of Erythrocytes to Thrombin Generation in Whole Blood , 1999, Thrombosis and Haemostasis.
[112] R. Doolittle,et al. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin , 1997, Nature.
[113] P. Reitsma,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.
[114] K. Carlsson,et al. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation. , 1994, Thrombosis research.
[115] E. Davie,et al. Factor XI deficiency in Ashkenazi Jews in Israel. , 1991, The New England journal of medicine.
[116] W. Stüber,et al. A Photometric Assay for Blood Coagulation Factor XIII , 1991, Thrombosis and Haemostasis.
[117] C. Francis,et al. Increased resistance to plasmic degradation of fibrin with highly crosslinked alpha-polymer chains formed at high factor XIII concentrations. , 1988, Blood.
[118] W. Kane,et al. Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. , 1988, Blood.
[119] R. D'Agostino,et al. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. , 1987, American heart journal.
[120] D. Dhall,et al. Effect of temperature, pH and ionic strength and composition on fibrin network structure and its development. , 1986, Thrombosis research.
[121] G. Crabtree,et al. Structure of the human gamma-fibrinogen gene. Alternate mRNA splicing near the 3' end of the gene produces gamma A and gamma B forms of gamma-fibrinogen. , 1984, The Journal of biological chemistry.
[122] E. Davie,et al. gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing. , 1984, Biochemistry.
[123] S. Olexa,et al. FIBRIN POLYMERIZATION SITES IN FIBRINOGEN AND FIBRIN FRAGMENTS * , 1983, Annals of the New York Academy of Sciences.
[124] M. Mosesson,et al. Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma'). , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[125] C. Francis,et al. Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen. , 1980, The Journal of biological chemistry.
[126] L. McIntire,et al. Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition. , 1975, The Journal of laboratory and clinical medicine.
[127] O. McCarty,et al. gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation. , 2008, Thrombosis and haemostasis.
[128] J. Weitz,et al. Bivalent binding to gammaA/gamma'-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex. , 2008, The Journal of biological chemistry.
[129] R. Bertina,et al. Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome. , 2007, Journal of thrombosis and haemostasis : JTH.
[130] R. Bertina,et al. Fibrinogen gamma in ischemic stroke: a case-control study , 2007 .
[131] R. Ariëns,et al. Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure. , 2003, Blood.
[132] H. Ni,et al. Association of gammaA/gamma' fibrinogen levels and coronary artery disease. , 2002, Thrombosis and haemostasis.
[133] J. Martinez,et al. The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains. , 1983, Blood.
[134] K. Mann. Prothrombin activation. , 1974, Human pathology.
[135] Stephanie A. Smith,et al. Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis Polyphosphate : A Novel Modulator of Hemostasis and Thrombosis , 2022 .